Evidence map›Paper›PMID 40169664›Full record

ArticleScientific data2025

Genome assembly resources of genitourinary cancers for chromosomal aberration at the single nucleotide level.

Hyunho Han, Hyung Ho Lee, Min Gyu Kim, Yoo Sub Shin, Jin Soo Chung, Jun Kim

Abstract readDataset
In one paragraph

Article in Scientific data, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Hyunho Han *Department of Urology, Urological Science Institute, Yonsei University College of Medicine, Seoul, Republic of Korea. TINTAL@yuhs.ac.
Hyung Ho Lee *Center for Urologic Cancer, National Cancer Center, Goyang, Republic of Korea.
Min Gyu KimCenter for Urologic Cancer, National Cancer Center, Goyang, Republic of Korea.
Yoo Sub ShinDepartment of Urology, Urological Science Institute, Yonsei University College of Medicine, Seoul, Republic of Korea.
Jin Soo ChungCenter for Urologic Cancer, National Cancer Center, Goyang, Republic of Korea. cjs5225@ncc.re.kr.
Jun KimDepartment of Convergent Bioscience and Informatics, College of Bioscience and Biotechnology, Chungnam National University, Daejeon, 34134, Korea. junkim@cnu.ac.kr.ORCID http://orcid.org/0000-0001-9753-4778

Funding

Korea Health Industry Development Institute (KHIDI) HI22C118600National Research Foundation of Korea (NRF) 2022R1I1A1A0107306512National Research Foundation of Korea (NRF) RS-2023-00247499
6 · The paper itself

Abstract

Traditionally, the evolutionary perspective of cancer has been understood as gradual alterations in passenger/driver genes that lead to branching phylogeny. However, in cases of prostate adenocarcinoma and kidney renal cell carcinoma, macroevolutionary landmarks like chromoplexy and chromothripsis are frequently observed. Unfortunately, short-read sequencing techniques often miss these significant macroevolutionary changes, which involve multiple translocations and deletions at the chromosomal level. To resolve such genomic dark matters, we provided high-fidelity long-read sequencing data (78-92 Gb of ~Q30 reads) of six genitourinary tumour cell lines (one benign kidney tumour and two kidney and three prostate cancers). Based on these data, we obtained 12 high-quality, partially phased genome assemblies (Contig N50 1.85-29.01 Mb; longest contig 2.02-171.62 Mb), graph-based pan-genome variant sets (11.57 M variants including 60 K structural variants), and 5-methylcytosine sites (14.68%-27.05% of the CpG sites). We also identified several severe chromosome aberration events, which would result from chromosome break and fusion events. Our cancer genome assemblies will provide unprecedented resolution to understand cancer genome instability and chromosomal aberration.

Indexed as

Chromosome AberrationsGenome, HumanUrogenital NeoplasmsCell Line, TumorHumansPolymorphism, Single Nucleotide

Identifiers

PMID40169664
PMCPMC11962096

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.